Giuliano, C.J., Lin, A., Smith, J.C., Palladino, A.C., and Sheltzer, J.M. (2017) Combining CRISPR/Cas9 mutagenesis and a small-molecule inhibitor to probe the function of MELK in cancer. bioRxiv.
Smith, J.C. and Sheltzer, J.M. (2017) An integrated analysis of the epigenetic, genetic, and transcriptional patterns associated with outcome across cancer types. bioRxiv.
Lin, A., Giuliano, C.J., Sayles, N.M., and Sheltzer, J.M. (2017) CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials. eLife, 6:e24179.
Sheltzer, J.M., Ko, J.C., Replogle, J.M., et al. (2017). Single-chromosome gains commonly function as tumor suppressors. Cancer Cell 31, 1-16.
Sheltzer, J. M., Smith, J. C. (2014) Elite male faculty in the life sciences employ fewer women. Proc Natl Acad Sci USA, 111 (28).
Sheltzer, J. M. (2013) A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis. Cancer Res 73 (21).
Sheltzer, J. M. and Torres, E. M. and Dunham, M. J. and Amon, A. (2012) Transcriptional consequences of aneuploidy. Proc Natl Acad Sci USA 109 (31).
Sheltzer, J. M. and Amon, A. (2011) The aneuploidy paradox: costs and benefits of an incorrect karyotype. Trends Genet 27 (11).
Sheltzer, J. M. and Blank, H. M. and Pfau, S. J. and Tange, Y. and George, B. M. and Humpton, T. J. and Brito, I. L. and Hiraoka, Y. and Niwa, O. and Amon, A. (2011) Aneuploidy drives genomic instability in yeast. Science 333 (6045).
Sheltzer, J.M. and Rose, M.D. (2009) The class V myosin Myo2p is required for Fus2p transport and actin polarization during the yeast mating response. Mol. Biol. Cell 20 (2909).